-
UK study to research long-term health impact of COVID-19
pharmatimes
July 07, 2020
The UK government has announced the launch of “one of the world’s largest comprehensive research studies” into the long-term health impacts of coronavirus on hospitalised patients.
-
UK researchers form consortium to monitor Covid-19 vaccines
pharmaceutical-technology
June 24, 2020
The University of Dundee’s Medicines Monitoring Unity (MEMO Research) and the Drug Safety Research Unit (DSRU) in the UK have formed a consortium to track the safety and effectiveness of Covid-19 vaccines.
-
UK launches scheme to encourage development of novel antibiotics
europeanpharmaceuticalreview
June 23, 2020
The NHS is offering two contracts to pay pharma companies at the start of their research into antibiotics, to promote the development of new antimicrobials.
-
UK launches world's first ‘subscription-style’ payment model for antibiotics
pharmatimes
June 22, 2020
A government scheme to fuel the development of new antibiotics by offering to pay pharmaceutical companies upfront for their work will start this week.
-
UK approves dexamethasone for Covid-19 patients after positive data
pharmaceutical-technology
June 18, 2020
The UK Government has authorised the use of anti-inflammatory drug dexamethasone for the treatment of Covid-19 on the National Health Service (NHS), immediately after the report of positive data from the RECOVERY trial.
-
MPs launch inquiry into UK asthma outcomes
pharmatimes
June 17, 2020
The All-Party Parliamentary Group for Respiratory Health is launching an enquiry into asthma and severe asthma outcomes in the UK.
-
UK funds human trials of Imperial College London’s COVID-19 vaccine research
expresspharma
June 17, 2020
Robin Shattock, a professor at Imperial’s department of infectious disease, said that rather than using a part of the virus, as many vaccines do, this potential vaccine uses synthetic strands of the virus’ genetic material - RNA - which are packaged ....
-
Coronavirus bottleneck leaves 2m waiting for cancer care
pharmatimes
June 04, 2020
Around 2.4 million people in the UK are currently waiting for cancer screening, tests or cancer treatment, a new analysis by Cancer Research UK has found.
-
UK's coronavirus testing capacity has been 'inadequate', Committee finds
pharmatimes
May 20, 2020
A committee of MPs has concluded that the UK's testing capacity during the novel coronavirus outbreak 'has been inadequate for most of the pandemic so far'.
-
UK provides funding support for Covid-19 vaccine programme
pharmaceutical-technology
May 19, 2020
The UK Government has committed to providing £84m in funding and manufacturing support to researchers working on Covid-19 vaccine programme, said Business Secretary Alok Sharma.